U.S. Department of Health & Human Services
National Institutes of Health
NCATS
Return Home
Inxight
Drugs
Search Substances
Home
Browse Drugs
US Approved Drugs
Marketed Drugs
Investigational Drugs
All Substances
Search
Structure Search
Sequence Search
Downloads
About
Search Substances
Gotistobart
4R46M31XXP
Investigational
General
Names
6
Identifiers
5
Subunits
4
Related Substances
1
Gotistobart
4R46M31XXP
Investigational
General
Approval Year
Unknown
139,594
Names
6
Show
5
20
100
All
entries
Name
Type
Language
Name
Type
Language
Gotistobart
Official Name
English
gotistobart [INN]
Common Name
English
Gamma1 heavy chain humanized (1-454) [VH (Homo sapiens IGHV4-59*01 (86.6%) -(IGHD) -IGHJ4*01(92.9%), CDR-IMGT [8.7.19] (26-33.51-57.96-114)) (1-125)-Homo sapiens IGHG1*01, G1m17,1 CH1 K120CH3 D12, L14, G1v6CH2 A85.4, A118, A119, G1v21CH2 Y15.1, T16, E18
Common Name
English
ONC-392
Code
English
Gotistobart (immunoglobulin G1-kappa, anti-[Homo sapiens CTLA4(cytotoxic T-lymphocyte-associated protein 4, CTLA-4, CD152)], humanized monoclonal antibody)
Common Name
English
Showing 1 to 5 of 6 entries
Previous
1
2
Next
Identifiers
5
Show
5
20
100
All
entries
Code System
Code
Type
Description
Code System
Code
Type
Description
INN
12383
PRIMARY
NCI_THESAURUS
C173547
PRIMARY
FDA UNII
4R46M31XXP
PRIMARY
CAS
2226344-78-9
PRIMARY
CLINICAL_TRIALS.GOV
NCT04140526
PRIMARY
Showing 1 to 5 of 5 entries
Previous
1
Next
Subunits
4
Subunit 0
>SUBUNIT_0
Subunit 1
>SUBUNIT_1
Subunit 2
>SUBUNIT_2
Subunit 3
>SUBUNIT_3
Related Substances
1
ACTIVE MOIETY
4R46M31XXP
Gotistobart